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Figure 2. Sample sites and pharmaceutical concentrations found within the Thames in 2016.
Perhaps of most concern for human health at present is the occurrence 
of a number of antimicrobials (AMs) and the potential build-up of 
associated antibiotic resistance in bacteria. AMs are the most important 
drugs in human and veterinary medicine to treat infectious diseases, 
but their widespread use and release into the environment even at low 
concentrations is of increasing concern. Unlike other contaminants, the 
level of concentration of an AM is not the only concern, it is the fact that 
it is in the environment and able to interact with microorganisms that 
could lead to antimicrobial resistance. Three surface water watch list 
AM’s (erythromycin, clarithromycin, azithromycin) were detected in the 
survey.
Conclusion
Many pharmaceuticals that are consumed by humans and animals end 
up in the aquatic environment, often in their original form. We are 
currently relying on dilution and dispersion as many treatment works do 
not effectively remove these substances. The presence of AMs within 
the environment and the potential for increasing antimicrobial 
resistance is of concern for human health.
Pharmaceuticals in the environment
Many of the pharmaceuticals that we take for health reasons will end 
up in the environment. There is a growing interest in the sources, 
occurrence and environmental impact of pharmaceuticals in the 
environment. Major sources include waste from manufacturers, 
excretion from humans or animals and incorrect disposal of unused 
pharmaceuticals (Figure 1).
Figure 1. Pharmaceutical pathways. Note: Waste water treatment works is WWTW  
The large range of compounds in wastewaters, found typically at µg/L 
concentrations, are difficult and costly to remove though current 
treatment options leading to discharge to surface waters followed by 
dilution and dispersion. Pharmaceuticals have been detected in 
groundwaters (e.g. Lapworth et al 2018) and surface waters (Figure 2). 
At present pharmaceuticals within the aquatic environment are below 
human therapeutic dose but the effect on aquatic organisms are being 
increasingly studied. An example of this is the potential risk of 
antihistamines to the aquatic ecosystem (Kristofco and Brooks 2017) 
and the effects of nonsteroidal anti-inflammatory drugs on birds 
(Cuthbert et al. 2007; Prakash et al. 2012).
Pharmaceuticals in the Thames
A recent winter study of the River Thames from source to sea (White et 
al, in review) using the Environment Agency’s LCMS scan showed the 
widespread occurrence of pharmaceuticals along the whole length of 
the Thames including at the groundwater dominated source. This study 
was carried out during high flows when dilution was high. The effects of 
the input of treated and non-treated waste water were discernible as 
certain substances, such as paracetamol, are biodegraded within the 
treatment process but were detected within the river at certain sites.
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